Datavault, Wellgistics to form DelivMeds AI via PharmacyChain license expansion

Datavault AI (DVLT) entered into a fully binding term sheet with Wellgistics Health (WGRX), integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx into its PharmacyChain, to build Wellgistics into DelivMeds AI following the completion of three concurrent transactions: 1) the expansion of Datavault AI’s previously disclosed PharmacyChain license to include Healthcare-as-a-Service-related intellectual property; 2) the acquisition of the QOLPOM intellectual property from EOS Technology Holdings and Scilex Holding Company (SCLX) that enables wearables-driven biometric confirmation of pharmacodynamic drug effect and biometric confirmation named-patient to receive home drug delivery; and 3) the acquisition of a controlling stake in Tollo Health. Together, the three transactions forming DelivMeds carry an expected approximate combined asset value of $4 billion, subject to an independent fairness opinion.